Target
Envelope glycoprotein gp160 [V370A]
Ligand
BDBM271441
Substrate
n/a
Meas. Tech.
MT4 Cell Antiviral Assay
EC50
411±n/a nM
Citation
 Johns, BA Compounds and compositions for treating HIV with derivatives of Betulin US Patent  US10064873 Publication Date 9/4/2018 
Target
Name:
Envelope glycoprotein gp160 [V370A]
Synonyms:
Envelope glycoprotein gp160 (V370A) | NL4-3 (V370A) | Q72502_9HIV1 | env
Type:
Enzyme Catalytic Domain
Mol. Mass.:
97003.09
Organism:
Human immunodeficiency virus 1
Description:
Q72502[V370A]
Residue:
854
Sequence:
MRVKEKYQHLWRWGWKWGTMLLGILMICSATEKLWVTVYYGVPVWKEATTTLFCASDAKAYDTEVHNVWATHACVPTDPNPQEVVLVNVTENFNMWKDDMVEQMHEDIISLWDQSLKPCVKLTPLCVSLKCTDLKNDTNTNSSSGRMIMEKGEIKNCSFNISTSIRDKVQKEYAFFYKLDIVPIDNTSYRLISCNTSVITQACPKVSFEPIPIHYCAPAGFAILKCNNKTFNGTGPCTNVSTVQCTHGIRPVVSTQLLLNGSLAEEDVVIRSANFTDNAKTIIVQLNTSVEINCTRPNNNTRKSIRIQRGPGRAFVTIGKIGNMRQAHCNISRAKWNATLKQIASKLREQFGNNKTIIFKQSSGGDPEIATHSFNCGGEFFYCNSTQLFNSTWFNSTWSTEGSNNTEGSDTITLPCRIKQFINMWQEVGKAMYAPPISGQIRCSSNITGLLLTRDGGNNNNGSEIFRPGGGDMRDNWRSELYKYKVVKIEPLGVAPTKAKRRVVQREKRAVGIGALFLGFLGAAGSTMGAASMTLTVQARQLLSDIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQQLLGIWGCSGKLICTTAVPWNASWSNKSLEQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWFNITNWLWYIKLFIMIVGGLVGLRIVFAVLSIVNRVRQGYSPLSFQTHLPIPRGPDRPEGIEEEGGERGRDRSIRLVNGSLALIWDDLRSLCLFSYHRLRDLLLIVTRIVELLGRRGWEALKYWWNLLQYWSQELKNSAVNLLNATAIAVAEGTDRVIEVLQAAYRAIRHIPRRIRQGLERILL
  
Inhibitor
Name:
BDBM271441
Synonyms:
4- (((3aS,5aR,5bR,7aR,9S, 11aR,11bR,13aS)-3a- ((S)-2- ((cyclohexylmethyl)amino)- 1-hydroxyethyl)-1- isopropyl-5a,5b,8,8,11a- pentamethyl- 3,3a,4,5,5a,5b,6,7,7a,8,9, 10,11,11a11b,12,13,13a- octadecahydro-2H- cyclopenta[a]chrysen-9- yl)oxy)-2,2-dimethyl-4- oxobutanoic acid | US10064873, Example 67
Type:
Small organic molecule
Emp. Form.:
C44H73NO5
Mol. Mass.:
696.0541
SMILES:
[H][C@]12CC[C@]3([H])[C@@]4(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@]4([H])CC[C@@]3(C)[C@]1(C)CC[C@]1(CCC(C(C)C)=C21)[C@H](O)CNCC1CCCCC1 |r,t:43,@:21|
Structure:
Search PDB for entries with ligand similarity: